BioCatalyst

aglatimagene besadenovec + valacyclovir, External Beam Radiation Therapy (EBRT) — catalyst calendar

1 verified catalyst event(s) referencing aglatimagene besadenovec + valacyclovir, External Beam Radiation Therapy (EBRT), each linked to its official source. Verified as of 2026-10-02.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02 (month)
in 4mo
ESTIMATED
 READOUT
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagen
Phase 2 · Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer (Adenocarcinoma)
 CADL Candel Therapeutics, Inc. aglatimagene besadenovec + valacyclovir, ClinicalTrials.gov ↗
✓ Source-checked 2026-10-02
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.